Hoth Therapeutics, Inc. Made Big Gain
Hoth Therapeutics, Inc. (HOTH:NASDAQ) soared at $1.24, a gain of 42.5%. On Tue, Mar 04, 2025, HOTH:NASDAQ touched a New 2-Week High of $1.24. The stock appeared on our News Catalysts scanner on Tue, Mar 04, 2025 at 11:14 AM in the 'MISCELLANEOUS' category. From Tue, Feb 18, 2025, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Tue, Jan 07, 2025 at $3.8 with a volume of 417M+.
About Hoth Therapeutics, Inc. (HOTH:NASDAQ)
Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
Top 10 Gainers:
- 908 Devices Inc. (MASS:NASDAQ), 95.96%
- Freight Technologies Inc Com (FRGT:NASDAQ), 54.9%
- Hoth Therapeutics, Inc. (HOTH:NASDAQ), 42.53%
- Jiuzi Holdings Inc. (JZXN:NASDAQ), 40.66%
- Rapport Therapeutics Inc. (RAPP:NASDAQ), 39.72%
- Critical Metals Corp. (CRML:NASDAQ), 36.53%
- Park Ha Biological Technology Co. Ltd. (PHH:NASDAQ), 31.92%
- Super League Enterprise Inc Com Par $0.001 (SLE:NASDAQ), 29.88%
- China Liberal Education Holdings Limited (CLEU:NASDAQ), 29.14%
- Jiayin Group Inc. (JFIN:NASDAQ), 26.17%